FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

216111000001107: Duragel 2% gel (SSL International Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17578901000001111 Duragel 2% gel (SSL International Plc) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17579001000001118 Duragel 2% gel (SSL International Plc) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Duragel 2% gel (SSL International Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Is a Product containing precisely nonoxinol 20 milligram/1 milliliter conventional release vaginal gel true Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Has specific active ingredient Nonoxinol 9 true Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Has active ingredient Nonoxinol 9 false Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Has active ingredient Nonoxinol false Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Is a Duragel true Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Has specific active ingredient Nonoxinol false Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Has active ingredient Nonoxinol 9 false Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Duragel 2% gel (SSL International Plc) 100 gram Is pack of False Duragel 2% gel (SSL International Plc) Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) 100 gram Has AMP True Duragel 2% gel (SSL International Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start